10.1001/jama.2021.3224 [DOI] [PMC free article] [PubMed] [Google Scholar] 67
Visceral adipose tissue is itself a primary driver of insulin resistance
Anyone experiencing adverse effects after using this substance should seek immediate medical attention and disclose their use to healthcare providers
Unlike standard dosing, microdosing GLP-1 allows patients to gradually adjust to treatment while minimizing side effects
GLP-1 medications are extremely powerful medications, so side effects and adverse events can occur when theyre prescribed to poorly selected patients without education, close monitoring, and support, says Saunders
Victoza (liraglutide) is FDA-approved to reduce the risk of major cardiovascular events like heart attack, stroke, and cardiovascular death in adults with type 2 diabetes and known heart disease